rs34203073

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018046.5(AGGF1):​c.397G>A​(p.Glu133Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0138 in 1,613,410 control chromosomes in the GnomAD database, including 196 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 14 hom., cov: 33)
Exomes 𝑓: 0.014 ( 182 hom. )

Consequence

AGGF1
NM_018046.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.05

Publications

14 publications found
Variant links:
Genes affected
AGGF1 (HGNC:24684): (angiogenic factor with G-patch and FHA domains 1) This gene encodes an angiogenic factor that promotes proliferation of endothelial cells. Mutations in this gene are associated with a susceptibility to Klippel-Trenaunay syndrome. Pseudogenes of this gene are found on chromosomes 3, 4, 10 and 16.[provided by RefSeq, Sep 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030573606).
BP6
Variant 5-77035624-G-A is Benign according to our data. Variant chr5-77035624-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 402345.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0142 (20774/1461240) while in subpopulation MID AF = 0.026 (150/5760). AF 95% confidence interval is 0.0226. There are 182 homozygotes in GnomAdExome4. There are 10210 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGGF1NM_018046.5 linkc.397G>A p.Glu133Lys missense_variant Exon 3 of 14 ENST00000312916.12 NP_060516.2 Q8N302-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGGF1ENST00000312916.12 linkc.397G>A p.Glu133Lys missense_variant Exon 3 of 14 1 NM_018046.5 ENSP00000316109.7 Q8N302-1
ENSG00000285000ENST00000646704.1 linkn.262G>A non_coding_transcript_exon_variant Exon 3 of 16 ENSP00000495089.1 A0A2R8YFF1

Frequencies

GnomAD3 genomes
AF:
0.00998
AC:
1518
AN:
152052
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00297
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.0280
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00394
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0156
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0102
AC:
2555
AN:
251246
AF XY:
0.0102
show subpopulations
Gnomad AFR exome
AF:
0.00271
Gnomad AMR exome
AF:
0.00749
Gnomad ASJ exome
AF:
0.0268
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.0153
Gnomad OTH exome
AF:
0.0157
GnomAD4 exome
AF:
0.0142
AC:
20774
AN:
1461240
Hom.:
182
Cov.:
31
AF XY:
0.0140
AC XY:
10210
AN XY:
726942
show subpopulations
African (AFR)
AF:
0.00272
AC:
91
AN:
33464
American (AMR)
AF:
0.00790
AC:
353
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0268
AC:
700
AN:
26114
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39588
South Asian (SAS)
AF:
0.00303
AC:
261
AN:
86226
European-Finnish (FIN)
AF:
0.00271
AC:
145
AN:
53412
Middle Eastern (MID)
AF:
0.0260
AC:
150
AN:
5760
European-Non Finnish (NFE)
AF:
0.0163
AC:
18150
AN:
1111600
Other (OTH)
AF:
0.0153
AC:
922
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1021
2042
3064
4085
5106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00997
AC:
1517
AN:
152170
Hom.:
14
Cov.:
33
AF XY:
0.00913
AC XY:
679
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.00294
AC:
122
AN:
41520
American (AMR)
AF:
0.0103
AC:
157
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0280
AC:
97
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00395
AC:
19
AN:
4814
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10590
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0156
AC:
1064
AN:
67994
Other (OTH)
AF:
0.0128
AC:
27
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
77
154
230
307
384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
42
Bravo
AF:
0.0104
TwinsUK
AF:
0.0140
AC:
52
ALSPAC
AF:
0.0140
AC:
54
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.0195
AC:
168
ExAC
AF:
0.00967
AC:
1174
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0186
EpiControl
AF:
0.0175

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27884173, 14961121, 16443853) -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AGGF1: BP4, BS1, BS2 -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 185/13004=1.4% -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
7.6
DANN
Benign
0.95
DEOGEN2
Benign
0.021
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.48
T;T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.8
L;L
PhyloP100
1.0
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.79
N;N
REVEL
Benign
0.092
Sift
Benign
0.074
T;T
Sift4G
Benign
0.32
T;D
Polyphen
0.0020
B;B
Vest4
0.28
MPC
0.21
ClinPred
0.0029
T
GERP RS
1.1
Varity_R
0.027
gMVP
0.24
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34203073; hg19: chr5-76331449; COSMIC: COSV99073292; API